Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ZYME
ZYME
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ZYME News
BETA Technologies Reports Disappointing Q4 Results
1d ago
Benzinga
Lisata Therapeutics to be Taken Private by Kuva Labs
1d ago
Benzinga
Zymeworks (ZYME.US) Insider Plans to Sell $6.13 Million Worth of Common Stock via Form 144
3d ago
moomoo
Zymeworks Q4 2025 Earnings Call Highlights
Mar 03 2026
seekingalpha
Zymeworks Reports 2025 Financials and $250 Million Financing Agreement
Mar 02 2026
NASDAQ.COM
Zymeworks Secures $250 Million Royalty Financing from Royalty Pharma
Mar 02 2026
NASDAQ.COM
Zymeworks Reports Expanded Losses in Q4
Mar 02 2026
NASDAQ.COM
Zymeworks Secures $250 Million Royalty-Backed Financing
Mar 02 2026
Globenewswire
Zymeworks Secures $250 Million Royalty-Backed Financing
Mar 02 2026
Newsfilter
Zymeworks Reports Q4 Earnings Miss with Significant Revenue Decline
Mar 02 2026
seekingalpha
Zymeworks Secures $250 Million Royalty-Backed Financing
Mar 02 2026
Yahoo Finance
Zymeworks Set to Announce Q4 Earnings on March 2
Feb 27 2026
seekingalpha
Redmile Group Significantly Reduces Zymeworks Stake
Feb 22 2026
Fool
Zymeworks Announces Q4 and Full Year 2025 Financial Results Release
Feb 12 2026
Newsfilter
Zymeworks (ZYME) 2026 Milestones Expected to Drive Long-Term Value with Promising ZW191 Data
Jan 12 2026
NASDAQ.COM
Zymeworks Appoints New Board Member and Executive Leadership Changes
Jan 12 2026
Globenewswire
Show More News
